[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
October 2004

5% Imiquimod Cream for the Treatment of Large Superficial Basal Cell Carcinoma

Arch Dermatol. 2004;140(10):1286-1287. doi:10.1001/archderm.140.10.1286

Two identical phase 3 studies have shown that 5% imiquimod cream is efficacious and safe for the treatment of typically sized (≤2.0 cm) superficial basal cell carcinomas (sBCCs).1 While most sBCCs are this size, a proportion are larger (≥2 cm).2,3 This study sought to determine if imiquimod would also be efficacious and safe for the treatment of larger sBCC.

First Page Preview View Large
First page PDF preview
First page PDF preview